Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Neal

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
BMJ Surgery, Interventions, & Health Technologies|January 20, 2022
Precision prostatectomy: reconciling functional and oncological outcomesDavid Neal
Psychiatria Danubina|September 30, 2015
A lot of mental illness starts in adolescence. Therefore should we shift some of the spending from adult to adolescent mental health services?David Neal
Expert Review of Anticancer Therapy|September 16, 2011
Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosisDavid Neal Franz
Biologics : Targets & Therapy|October 22, 2013
Everolimus in the treatment of subependymal giant cell astrocytomas, angiomyolipomas, and pulmonary and skin lesions associated with tuberous sclerosis complexDavid Neal Franz
Journal of Child Neurology|November 26, 2004
Non-neurologic manifestations of tuberous sclerosis complexDavid Neal Franz
JAMA|March 21, 2002
Meningiomas in women with lymphangioleiomyomatosisDavid Neal Franz
Developmental Medicine and Child Neurology|July 22, 2022
Changing the outcome in genetic brain disordersDavid Neal Franz
Epilepsia|August 19, 2007
mTOR in tuberous sclerosis and other neurological disordersDavid Neal Franz
Lancet (London, England)|April 16, 2013
Everolimus for astrocytomas in tuberous sclerosis - author's replyDavid Neal Franz
European Urology|June 27, 2016
Circulating Tumor Cell Count as an Indicator of Treatment Benefit in Advanced Prostate CancerDavid Neal, Hans Lilja
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
BMJ Surgery, Interventions, & Health Technologies|January 20, 2022
Precision prostatectomy: reconciling functional and oncological outcomesDavid Neal
Psychiatria Danubina|September 30, 2015
A lot of mental illness starts in adolescence. Therefore should we shift some of the spending from adult to adolescent mental health services?David Neal
Expert Review of Anticancer Therapy|September 16, 2011
Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosisDavid Neal Franz
Biologics : Targets & Therapy|October 22, 2013
Everolimus in the treatment of subependymal giant cell astrocytomas, angiomyolipomas, and pulmonary and skin lesions associated with tuberous sclerosis complexDavid Neal Franz
Journal of Child Neurology|November 26, 2004
Non-neurologic manifestations of tuberous sclerosis complexDavid Neal Franz
JAMA|March 21, 2002
Meningiomas in women with lymphangioleiomyomatosisDavid Neal Franz
Developmental Medicine and Child Neurology|July 22, 2022
Changing the outcome in genetic brain disordersDavid Neal Franz
Epilepsia|August 19, 2007
mTOR in tuberous sclerosis and other neurological disordersDavid Neal Franz
Lancet (London, England)|April 16, 2013
Everolimus for astrocytomas in tuberous sclerosis - author's replyDavid Neal Franz
European Urology|June 27, 2016
Circulating Tumor Cell Count as an Indicator of Treatment Benefit in Advanced Prostate CancerDavid Neal, Hans Lilja
Pageof 13